The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.
about
Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequencesThe use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene deliveryVirological events leading to spontaneous AKR thymomasPathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J miceOrigins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice.Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses.Association of recombinant murine leukemia viruses of the class II genotype with spontaneous lymphomas in CWD mice.Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity.Identification and characterization of an enhancer in the coding region of the genome of human immunodeficiency virus type 1.Porcine endogenous retroviruses in xenotransplantation--molecular aspectsMembers of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression.In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell typesLong terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas.Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cellsIkaros, a lymphoid-cell-specific transcription factor, contributes to the leukemogenic phenotype of a mink cell focus-inducing murine leukemia virusAnalysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virusRole of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndromeSequence analysis of porcine endogenous retrovirus long terminal repeats and identification of transcriptional regulatory regionsIdentification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus.Koala retroviruses: characterization and impact on the life of koalas.Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.Receptor-mediated leukaemogenesis: hypothesis revisitedIdentification of a new common provirus integration site in gross passage A murine leukemia virus-induced mouse thymoma DNA.The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicityRadiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor V beta gene products.Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activitiesMolecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.Acute myeloid leukemia induction by amphotropic murine retrovirus (4070A): clonal integrations involve c-myb in some but not all leukemiasIdentification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific elementIdentification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumorsDifferences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties
P2860
Q24645275-932F8481-1071-41F6-AD62-29923500E85AQ24804110-B3A2E595-7859-467C-A3B4-AD93AD7E2B6DQ28279811-1E16C914-36A9-4984-9EB4-98BA6829C46EQ30452113-683A41BF-A83D-4E45-B12D-DA5F7865F0DCQ30452120-58C9B12B-85C3-4DE6-A8C2-E15965F32B06Q30452207-3B0E626A-60E8-41B6-9195-A4D0BB0D50C5Q30452250-F129CAC9-22BF-462F-8594-C2EE0936C2F9Q33639086-4DE0944E-9544-4DE6-A9AE-DB05B6B28F7FQ33649460-3D2BF7C3-1C5F-4E1F-9064-3A323E998AF7Q33677528-09398C50-4D9E-48C1-96CE-87BC8C38A14FQ33785027-4B61808A-513F-4AD3-9D01-8F423C9604FDQ33785327-A7C0DFF5-ED7F-4812-9219-E462E0F8233EQ33811928-3630A584-D185-4716-909A-82278F4F1168Q33814106-4BBAA7B8-6FFE-47D4-A6A2-C1593B232E0BQ33850552-3EDAB447-B864-409D-92B1-2076962CBFF7Q33879304-0C390399-3F3E-4583-A3DF-3F46C1C1D358Q34120342-2B3D6B19-1966-4D9F-9226-03194D25E228Q34327052-BC3271BE-3388-4D88-B006-CB2AE3DC241EQ34328436-43BDF05B-1BD8-4885-B076-4B0BF70AFC0DQ34340270-8976127A-3906-40C5-B28A-40CEB457280BQ34462379-BEE542CB-77EC-4FFE-89DE-52169F02908AQ34463374-90CEE67F-7FE7-450D-B8A9-F73597387077Q35024018-48A5A7BF-1412-4D4C-B2B3-E95B5C4ED6D3Q35839448-46E60009-0FD0-4A17-89F1-2A61E9C4042EQ35887850-D699EB7B-FAC0-41CF-86C1-57623E45AED3Q35894998-2BC49ED6-1345-4CD0-A76D-01D3F46157CCQ35940563-3850A7F0-B813-4964-95CE-A2FA41804616Q36290235-AB0E303F-CB01-4E3B-9B62-2F1AAEA56047Q36426627-E14F60C2-AF9F-46EA-BA25-8B42D41233C0Q36549315-3D93B762-2408-45FE-B08D-7EA01943EA94Q36627545-FE8E614B-D611-4935-A18E-152D431995CCQ36633701-83B3700E-C885-4F6D-8CCB-FA482A3F7F95Q36636839-F81992B7-0A95-4D09-A43A-B673F10FC487Q36686005-53FD2111-91C9-486B-A0A2-0AAEA278C8FEQ36686016-C6F451DD-2DFF-4116-B9C5-5019B1B6C8A6Q36701088-BA1B7E48-1661-4B03-9D8C-4194F2664196Q36779962-3286CA57-EFE3-42DC-A06C-98D1F151BE8AQ36780634-9F189352-713E-4543-A7C2-5DB8DE7831F1Q36781432-85413C3A-0CF3-4A2D-B08A-865F8936190EQ36796214-58DB38CC-F073-4A3E-BD80-0D086CF43208
P2860
The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The tandem direct repeats with ...... their leukemogenic potential.
@en
type
label
The tandem direct repeats with ...... their leukemogenic potential.
@en
prefLabel
The tandem direct repeats with ...... their leukemogenic potential.
@en
P2860
P1433
P1476
The tandem direct repeats with ...... their leukemogenic potential.
@en
P2093
DesGroseillers L
Jolicoeur P
P2860
P304
P407
P577
1984-12-01T00:00:00Z